CU

Christian Uhrich

Investments at M Ventures

Karlsruhe, Baden-Württemberg

Overview 

Christian Uhrich is an Investment Director specializing in Biotechnology Investments at M Ventures, with a strong background in venture capital and entrepreneurship. He holds a leadership position overseeing investment strategies and has served on multiple boards of directors within the biotech industry. Uhrich's career highlights include his role as Head of Strategy at M Ventures and his involvement on the boards of LabGenius, Indi Molecular, and other biotech companies, showcasing his expertise in business development and strategic decision-making in the field of biotechnology investments.

Work Experience 

  • Investment Director, Biotechnology Investments

    2021 - Current

  • Head of Strategy

    2019 - 2021

  • Board Observer

    2024

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Raised $165,000,000.00 from CRV, RA Capital Management, Pappas Capital, DCVC Bio, SoftBank Vision Fund, Pivotal bioVenture Partners, M Ventures, Surveyor Capital, Lux Capital and Neotribe Ventures.

  • Member Board of Directors

    2024

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

Raised $136,200,000.00 from ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.

  • Board Observer

    2024

  • Member Board of Directors

    2023

Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic.

Raised $13,300,000.00 from M Ventures, SABEY, Legend Capital and Asset Management Ventures (AMV).

  • Member Board of Directors

    2023

  • Board Observer

    2023

  • Member Board of Directors

    2022

  • Member Board of Directors

    2022

  • Board Observer

    2022

Articles About Christian

Relevant Websites